The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Targeted DNA & RNA Sequencing-Global Market Insights and Sales Trends 2025
Synopsis
The global Targeted DNA & RNA Sequencing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Targeted DNA & RNA Sequencing in various end use industries. The expanding demands from the Human Biomedical Research, Plant & Animal Sciences, Drug Discovery and Others, are propelling Targeted DNA & RNA Sequencing market. DNA-based Targeted Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA-based Targeted Sequencing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Targeted DNA & RNA Sequencing market, driven by demand from China, the second largest economy with some signs of stabilising, the Targeted DNA & RNA Sequencing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Targeted DNA & RNA Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Targeted DNA & RNA Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Targeted DNA & RNA Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Targeted DNA & RNA Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Targeted DNA & RNA Sequencing covered in this report include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN and BGI, etc.
The global Targeted DNA & RNA Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.
Global Targeted DNA & RNA Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Targeted DNA & RNA Sequencing market, Segment by Type:
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Global Targeted DNA & RNA Sequencing market, by Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Targeted DNA & RNA Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Targeted DNA & RNA Sequencing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Targeted DNA & RNA Sequencing in various end use industries. The expanding demands from the Human Biomedical Research, Plant & Animal Sciences, Drug Discovery and Others, are propelling Targeted DNA & RNA Sequencing market. DNA-based Targeted Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA-based Targeted Sequencing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Targeted DNA & RNA Sequencing market, driven by demand from China, the second largest economy with some signs of stabilising, the Targeted DNA & RNA Sequencing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Targeted DNA & RNA Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Targeted DNA & RNA Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Targeted DNA & RNA Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Targeted DNA & RNA Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Targeted DNA & RNA Sequencing covered in this report include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN and BGI, etc.
The global Targeted DNA & RNA Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.
Global Targeted DNA & RNA Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Targeted DNA & RNA Sequencing market, Segment by Type:
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Global Targeted DNA & RNA Sequencing market, by Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Targeted DNA & RNA Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Targeted DNA & RNA Sequencing
1.1 Targeted DNA & RNA Sequencing Market Overview
1.1.1 Targeted DNA & RNA Sequencing Product Scope
1.1.2 Targeted DNA & RNA Sequencing Market Status and Outlook
1.2 Global Targeted DNA & RNA Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Targeted DNA & RNA Sequencing Market Size by Region (2018-2029)
1.4 Global Targeted DNA & RNA Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Targeted DNA & RNA Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Targeted DNA & RNA Sequencing Market Size (2018-2029)
1.6.1 North America Targeted DNA & RNA Sequencing Market Size (2018-2029)
1.6.2 Europe Targeted DNA & RNA Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Targeted DNA & RNA Sequencing Market Size (2018-2029)
1.6.4 Latin America Targeted DNA & RNA Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Targeted DNA & RNA Sequencing Market Size (2018-2029)
2 Targeted DNA & RNA Sequencing Market by Type
2.1 Introduction
2.1.1 DNA-based Targeted Sequencing
2.1.2 RNA-based Targeted Sequencing
2.2 Global Targeted DNA & RNA Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Targeted DNA & RNA Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Targeted DNA & RNA Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Targeted DNA & RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Targeted DNA & RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Targeted DNA & RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Targeted DNA & RNA Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Targeted DNA & RNA Sequencing Revenue Breakdown by Type (2018-2029)
3 Targeted DNA & RNA Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Human Biomedical Research
3.1.2 Plant & Animal Sciences
3.1.3 Drug Discovery
3.1.4 Others
3.2 Global Targeted DNA & RNA Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Targeted DNA & RNA Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Targeted DNA & RNA Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Targeted DNA & RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Targeted DNA & RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Targeted DNA & RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Targeted DNA & RNA Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Targeted DNA & RNA Sequencing Revenue Breakdown by Application (2018-2029)
4 Targeted DNA & RNA Sequencing Competition Analysis by Players
4.1 Global Targeted DNA & RNA Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted DNA & RNA Sequencing as of 2022)
4.3 Date of Key Players Enter into Targeted DNA & RNA Sequencing Market
4.4 Global Top Players Targeted DNA & RNA Sequencing Headquarters and Area Served
4.5 Key Players Targeted DNA & RNA Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Targeted DNA & RNA Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina, Inc.
5.1.1 Illumina, Inc. Profile
5.1.2 Illumina, Inc. Main Business
5.1.3 Illumina, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.1.4 Illumina, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina, Inc. Recent Developments
5.2 F. Hoffmann-La Roche Ltd
5.2.1 F. Hoffmann-La Roche Ltd Profile
5.2.2 F. Hoffmann-La Roche Ltd Main Business
5.2.3 F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Ltd Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Targeted DNA & RNA Sequencing Products, Services and Solutions
5.3.4 Agilent Technologies Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 GATC Biotech Ag Recent Developments
5.4 GATC Biotech Ag
5.4.1 GATC Biotech Ag Profile
5.4.2 GATC Biotech Ag Main Business
5.4.3 GATC Biotech Ag Targeted DNA & RNA Sequencing Products, Services and Solutions
5.4.4 GATC Biotech Ag Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 GATC Biotech Ag Recent Developments
5.5 Oxford Nanopore Technologies
5.5.1 Oxford Nanopore Technologies Profile
5.5.2 Oxford Nanopore Technologies Main Business
5.5.3 Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Products, Services and Solutions
5.5.4 Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 Oxford Nanopore Technologies Recent Developments
5.6 Thermo Fisher Scientific, Inc.
5.6.1 Thermo Fisher Scientific, Inc. Profile
5.6.2 Thermo Fisher Scientific, Inc. Main Business
5.6.3 Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific, Inc. Recent Developments
5.7 DNASTAR Inc.
5.7.1 DNASTAR Inc. Profile
5.7.2 DNASTAR Inc. Main Business
5.7.3 DNASTAR Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.7.4 DNASTAR Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 DNASTAR Inc. Recent Developments
5.8 QIAGEN
5.8.1 QIAGEN Profile
5.8.2 QIAGEN Main Business
5.8.3 QIAGEN Targeted DNA & RNA Sequencing Products, Services and Solutions
5.8.4 QIAGEN Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 QIAGEN Recent Developments
5.9 BGI
5.9.1 BGI Profile
5.9.2 BGI Main Business
5.9.3 BGI Targeted DNA & RNA Sequencing Products, Services and Solutions
5.9.4 BGI Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.9.5 BGI Recent Developments
5.10 Perkin Elmer, Inc.
5.10.1 Perkin Elmer, Inc. Profile
5.10.2 Perkin Elmer, Inc. Main Business
5.10.3 Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.10.4 Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.10.5 Perkin Elmer, Inc. Recent Developments
5.11 Pacific Biosciences of California, Inc.
5.11.1 Pacific Biosciences of California, Inc. Profile
5.11.2 Pacific Biosciences of California, Inc. Main Business
5.11.3 Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.11.4 Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.11.5 Pacific Biosciences of California, Inc. Recent Developments
5.12 Bio-Rad Laboratories, Inc.
5.12.1 Bio-Rad Laboratories, Inc. Profile
5.12.2 Bio-Rad Laboratories, Inc. Main Business
5.12.3 Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.12.4 Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.12.5 Bio-Rad Laboratories, Inc. Recent Developments
5.13 Integrated DNA Technologies, Inc.
5.13.1 Integrated DNA Technologies, Inc. Profile
5.13.2 Integrated DNA Technologies, Inc. Main Business
5.13.3 Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.13.4 Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.13.5 Integrated DNA Technologies, Inc. Recent Developments
5.14 RainDance Technologies, Inc.
5.14.1 RainDance Technologies, Inc. Profile
5.14.2 RainDance Technologies, Inc. Main Business
5.14.3 RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.14.4 RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.14.5 RainDance Technologies, Inc. Recent Developments
5.15 PierianDx
5.15.1 PierianDx Profile
5.15.2 PierianDx Main Business
5.15.3 PierianDx Targeted DNA & RNA Sequencing Products, Services and Solutions
5.15.4 PierianDx Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.15.5 PierianDx Recent Developments
5.16 Genomatix GmbH
5.16.1 Genomatix GmbH Profile
5.16.2 Genomatix GmbH Main Business
5.16.3 Genomatix GmbH Targeted DNA & RNA Sequencing Products, Services and Solutions
5.16.4 Genomatix GmbH Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.16.5 Genomatix GmbH Recent Developments
5.17 Macrogen, Inc.
5.17.1 Macrogen, Inc. Profile
5.17.2 Macrogen, Inc. Main Business
5.17.3 Macrogen, Inc. Targeted DNA & RNA Sequencing Products, Services and Solutions
5.17.4 Macrogen, Inc. Targeted DNA & RNA Sequencing Revenue (US$ Million) & (2018-2023)
5.17.5 Macrogen, Inc. Recent Developments
6 North America
6.1 North America Targeted DNA & RNA Sequencing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Targeted DNA & RNA Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Targeted DNA & RNA Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Targeted DNA & RNA Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Targeted DNA & RNA Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Targeted DNA & RNA Sequencing Market Dynamics
11.1 Targeted DNA & RNA Sequencing Industry Trends
11.2 Targeted DNA & RNA Sequencing Market Drivers
11.3 Targeted DNA & RNA Sequencing Market Challenges
11.4 Targeted DNA & RNA Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
